This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Immunization  • Alert me on articles by topic

JAMA. 2007;297:1052-1054.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

MMWR. 2006;55:988-993

1 figure, 2 tables omitted

The National Immunization Survey (NIS) provides vaccination coverage estimates among children aged 19-35 months for each of the 50 states and selected urban areas.* Findings from the 2005 NIS include nationwide increases in coverage with 3 and 4 doses of pneumococcal conjugate vaccine (PCV) and continued high levels of coverage for the other recommended vaccines and vaccine series. In addition, no racial/ethnic disparities in coverage estimates were observed in the 4:3:1:3:3:1 vaccine series, the recommended series for children aged 19-35 months that includes DTP/DT/DTaP; poliovirus vaccine; measles, mumps, and rubella vaccine (MMR); Haemophilus influenzae type b vaccine; hepatitis B vaccine; and varicella vaccine. An important accomplishment indicated by the 2005 NIS data is the achievement of >50% coverage for the full series of PCV (4 doses) and >80% coverage for 3 doses within 5 years after being added to the U.S.-recommended childhood . . . [Full Text of this Article]

Reported by: